相关实验视频
Updated: May 16, 2025
09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
297
为癌症提供纳米治疗配方 抗血管新生药 抗血管新生药
Amelia Ultimo1, Ayushi Jain1, Elisabet Gomez-Gonzalez1
1School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, the University of Dublin, College Green, Dublin 2 D02 PN40, Ireland.
Molecular pharmaceutics
|April 4, 2025
概括
纳米疗法提供了一种有前途的方法,通过向瘤血管和改善药物输送来增强抗血管性癌症治疗. 这些纳米配方可以克服传统治疗的局限性,潜在地阻止瘤生长和转移.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 抗血管原药单独在延长癌症患者存活时间方面具有有限的有效性.
- 长时间服用抗血管原剂往往无法阻止瘤的进展.
- 纳米疗法为改善抗血管原性癌症治疗提供了一个新的策略.
研究的目的:
- 审查抗血管性癌症治疗纳米配方的最新进展.
- 突出纳米疗法如何克服传统抗血管原性治疗的局限性.
- 讨论纳米医学在向瘤血管和控制血管生成方面的潜力.
主要方法:
- 对纳米配方的审查,包括聚合纳米粒子,无机纳米粒子,囊泡和水凝.
- 讨论加载抗血管原性物质,如内静止素和介质蛋白-12.
- 对针对亲血管性通路 (VEGF,Tie2/Angiopoietin-1,HIF-1α/HIF-2α,TGF-β) 的纳米配方进行分析.
主要成果:
- 纳米疗法使瘤血管系统的向输送成为可能,增强药物积累.
- 纳米配方促进了抗血管原剂的控制释放,减少了副作用.
- 通过使用纳米载体,同时使用多种血管生成抑制剂和化疗是可行的.
结论:
- 纳米治疗药物具有显著的潜力,可以提高抗血管原性癌症治疗的疗效.
- 通过纳米医药的向输送和受控释放可以增强药物积累并最大限度地降低毒性.
- 纳米配方提供了创新的策略,通过调节关键血管新生通路来阻止瘤生长和转移.
更多相关视频
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
2.4K
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
13.8K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
01:22Drug Delivery: Miscellaneous Routes
286
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
286
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:10Mechanism of Angiogenesis
5.1K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.1K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K